Rare diseases

Therapeutic solutions for rare diseases

Over 2/3 of LFB’s medicinal products are indicated for rare diseases, making it a major player in this field. LFB’s medicinal products help hospital-based healthcare professionals treat patients with diseases that are sometimes very rare and for which there are few therapeutic options.

What is a rare disease ?

The term “rare disease” refers to a condition affecting fewer than 1 in 2,000 people* in Europe, and about 3 million in France, suffer from a rare disease in 2016*.

In the world we estimate that 263 to 446 million people is affected by a rare disease, which equates to 3.5–5.9% of the worldwide population**. There are 7,000 to 8,000 rare diseases worldwide, 80% of which are of genetic origin. In Europe 30 million* people have a rare disease. Haemophilia, Primary Immunodeficiency (PID), immune-mediated neuropathies, deficiencies of certain proteins, are all rare diseases that profoundly affect people’s lives.

* Sources:
** “Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database” Authors: Stéphanie Nguengang, Wakap, Deborah M. Lambert, Annie Olry, Charlotte Rodwell, Charlotte Gueydan, Valérie Lanneau, Daniel Murphy, Yann Le Cam & Ana RathDA – Published 2019/09/16 in the European Journal of Human Genetics.